ISRCTN68472863终止未知
Development and Clinical Trial of a Mixed (Multi/Single-use) Catheter Management Package for Users of Intermittent Catheterisation (The MultICath Study)
niversity of Southampton0 个研究点目标入组 500 人开始时间: 2016年3月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 16 years and over
- •2. Intermittent catheterisation planned to continue for 12 months
- •3. Able and willing to adhere to a 12-month follow up period
- •4. Currently using or preparing to start using intermittent catheterisation (via the urethra), performed by self or sole carer
- •5. Patient has provided written informed consent for participation in the study prior to any study specific procedures
排除标准
- •1. Aged below 16 years
- •2. Use of IC for self-dilatation of urethral stricture (ISD) without bladder drainage
- •3. Non-urethral route for catheterisation e.g. Mitrofanoff
- •4. External carer required for IC (i.e. where sterile technique and catheter is required e.g. visiting community nurse performs IC)
- •5. Inability to give informed consent or have primary outcome information collected
- •6. Women who are pregnant, planning to become pregnant or breast feeding during the trial
研究者
相似试验
已完成
不适用
A prospective clinical trial of a multidisciplinary electronic cardiovascular prevention programmePrevention of Cardiovascular diseasesCirculatory SystemCardiovascular diseasesISRCTN23940498De Onderlinge Ziekenkas (Belgium)350
已完成
不适用
Self management and support programme (EDGE) for COPDChronic obstructive pulmonary disease.RespiratoryChronic obstructive pulmonary disease, unspecifiedISRCTN40367841Oxford University (UK)295
进行中（未招募）
不适用
Clinical trial to evaluate the treatment with a drug (lenalidomide) with the usually prescribed chemotherapy in patients diagnosed with diffuse large B-cell lymphoma (sort of blood cancer) which did not respond to previous treatments and who can not receive high-dose chemotherapy.EUCTR2014-001620-29-ESGrupo Español para el Tratamiento y Estudio de los Linfomas (GOTEL)77
尚未招募
2 期
Phase II clinical trial of multidisciplinary therapy using risk classification based on residual tumor volume and WHO grading for pediatric ependymoma patients (JCCG EPN1501)JPRN-UMIN000023803The Japan Children's Cancer Group(JCCG)40
进行中（未招募）
1 期
Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients.EUCTR2018-003300-39-ESFundación para la Investigación Biomédica de Córdoba150